Yunao Ning (御脑宁A+C)御脑宁A+C

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

C群脑膜炎奈瑟氏菌培养液 经提取获得的荚膜多糖抗原 纯化后加入乳糖作为稳定剂冻干制成是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:经提取获得的荚膜多糖抗原Jingti Quhuo Dede Jiamo Duotang Kangyuan。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:经提取获得的荚膜多糖抗原-a4118ab5成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 御脑宁A+C) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 经提取获得的荚膜多糖抗原Jingti Quhuo Dede Jiamo Duotang Kangyuan.

Explore other medicines containing the same ingredient: 经提取获得的荚膜多糖抗原 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 御脑宁A+CRecorded Chinese name: 御脑宁A+C
  • 规格Specification: 1人用剂量/支,含A群多糖50μg、C群多耱50μg。复溶后为0.5ml。Recorded Chinese description: 1人用剂量/支,含A群多糖50μg、C群多耱50μg。复溶后为0.5ml。

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 浙江天元生物药业有限公司Chinese legal name: 浙江天元生物药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字S20070021

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字S20070021

Manufacturer

Chinese legal name: 浙江天元生物药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字S20070021

生产企业

浙江天元生物药业有限公司(国产)

适应症

接种疫苗后,可使机体产生体液免疫应答。用于预防A群和c群脑膜炎球菌引起的流行性脑脊髓膜炎。2岁以下婴幼儿建议使用结合疫苗。

用法用量

【接种对象】2周岁以上儿童及成人。接种应于流脑流行季节前完成。【免疫程序和剂量】(1)按标示量加入所附PBS复溶,摇匀立即使用。(2)途径:于上臂外侧三角肌附着处皮下注射。(3)剂量:每次1人用剂量(0.5ml)。(4)接种次数:一次。有研究提示根据首次接种的年龄、暴露风险和血清类型,2-4年同类疫苗需再次接种。本品尚未进行此方面研究。

不良反应

接种本疫苗可发生发热、皮疹等不良反应,注射局部可能出现疼痛、红肿或搔痒,可以自行缓解。极少数的儿童还可能出现头痛、乏力、嗜睡或烦躁、消化道不适等全身反应。

禁忌

(1)有癫痫、惊厥及过敏吏者。 |(2)患脑部疾患、肾脏病、心脏病及活动性结核者。|(3)患急性传染病及发热者。

注意事项

(1)严禁血管内注射。|(2)接种所有疫苗均频有肾上腺素等药物及合理监护措施,以防发生罕见的超敏反应。|(3)疫苗瓶塞有松动,复溶后有异物或疫苗瓶有裂纹,均不得使用。|(4)疫苗复溶后,应按规定剂量一次用完,不得分多次使用。

贮藏

于2--8℃避光保存和运输。

规格

1人用剂量/支,含A群多糖50μg、C群多耱50μg。复溶后为0.5ml。

证据Evidence

  • 批准文号: 国药准字S20070021
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.